Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease

   


1. Belarusian State University, Minsk, Belarus
2. Institute for Experimental Medicine, Saint-Petersburg, Russia; Research Institute of Physical-Chemical Medicine, Moscow, Russia
3. Scientific practical centre of hygiene republican unitary enterprise, Minsk, Belarus
4. Institute for Experimental Medicine, Saint-Petersburg, Russia
5. Republican Science-Practical Center of Cardiology, Minsk, Belarus
6. Research Institute of Physical-Chemical Medicine, Moscow, Russia
Type: Clinical and diagnostic research
DOI: 10.18097/PBMC20166203318      UDK: 577.152.193.01:616.127-005.8      PubMed Id: 27420626
Year: 2016 vol: 62  issue:3  pages: 318-324
Abstract: A significant increase in the myeloperoxidase (MPO) activity has been found in plasma of patients with stable angina and with acute coronary syndrome (ACS) in comparison with the control group. MPO concentration was significantly increased in plasma of ACS patients. Reduced MPO activity in the treated ACS patients correlated with a favorable outcome of the disease. Generally, changes in plasma MPO concentration coincided with changes in lactoferrin concentration thus confirming the role of neutrophil degranulation in the increase of plasma concentrations of these proteins. The increase in MPO activity was obviously determined by modification of the MPO protein caused by reactive oxygen species and halogen in the molar ratio of 1 : 25 and 1 : 50. The decrease in plasma MPO activity may be associated with increased plasma concentrations of the physiological inhibitor of its activity, ceruloplasmin, and also with modification of the MPO protein with reactive oxygen species and halogen at their molar ratio of 1 : 100 and higher. Thus, MPO activity may be used for evaluation of effectiveness of the treatment of cardiovascular diseases.
Download PDF:
Reference: Grigorieva D.V., Gorudko I.V., Kostevich V.A., Sokolov A.V., Buko I.V., Vasilyev V.B., Polonetsky L.Z., Panasenko O.M., Cherenkevich S.N., Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease, Biomeditsinskaya khimiya, 2016, vol: 62(3), 318-324.
This paper is also available as the English translation:10.1134/S1990750816020050
References
 2017(Vol:63)
 2016(Vol:62)
 2015(Vol:61)
 2014(Vol:60)
 2013(Vol:59)
 2012(Vol:58)
 2011(Vol:57)
 2010(Vol:56)
 2009(Vol:55)
 2008(Vol:54)
 2007(Vol:53)
 2006(Vol:52)
 2005(Vol:51)
 2004(Vol:50)
 2003(Vol:49)